- Report
- September 2024
- 82 Pages
Japan
From €3122EUR$3,500USD£2,678GBP
- Report
- September 2024
- 82 Pages
Japan
From €3122EUR$3,500USD£2,678GBP
- Report
- August 2024
- 82 Pages
Japan
From €3122EUR$3,500USD£2,678GBP
- Report
- September 2026
- 120 Pages
From €7127EUR$7,990USD£6,113GBP
- Report
- August 2026
- 150 Pages
From €3345EUR$3,750USD£2,869GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Report
- January 2025
- 176 Pages
Global
From €7091EUR$7,950USD£6,082GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3345EUR$3,750USD£2,869GBP
- Report
- July 2024
- 231 Pages
Global
From €7091EUR$7,950USD£6,082GBP
- Report
- June 2024
- 206 Pages
Global
From €7091EUR$7,950USD£6,082GBP
- Report
- March 2023
- 30 Pages
Global
From €2899EUR$3,250USD£2,486GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2230EUR$2,500USD£1,913GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more